Publication: Single-agent daratumumab in patients with relapsed and refractory multiple myeloma requiring dialysis: results of a Spanish retrospective, multicentre study.
No Thumbnail Available
Identifiers
Date
2019-12-02
Authors
Cejalvo, María J
Legarda, Mario
Abella, Eugenia
Cabezudo, Elena
Encinas, Cristina
García-Feria, Ana
Gironella, Mercedes
Iñigo, Belén
Martín, Jesús
Ribas, Paz
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Export
Abstract
Description
MeSH Terms
Aged
Antibodies, Monoclonal
Disease-Free Survival
Female
Humans
Male
Middle Aged
Multiple Myeloma
Recurrence
Renal Dialysis
Retrospective Studies
Survival Rate
Antibodies, Monoclonal
Disease-Free Survival
Female
Humans
Male
Middle Aged
Multiple Myeloma
Recurrence
Renal Dialysis
Retrospective Studies
Survival Rate
DeCS Terms
CIE Terms
Keywords
daratumumab, dialysis, multiple myeloma, relapse